Viewing Study NCT00332761


Ignite Creation Date: 2025-12-24 @ 1:07 PM
Ignite Modification Date: 2025-12-29 @ 7:22 PM
Study NCT ID: NCT00332761
Status: COMPLETED
Last Update Posted: 2021-01-27
First Post: 2006-06-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Caduet in an Untreated Subject Population
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A3841046
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators